AstraZeneca CEO’s £1.8mn pay rise approved despite shareholder opposition

Posted
AstraZeneca hiked its dividend to persuade shareholders to accept CEO Pascal Soriot’s pay rise. Is he worth his salary?

Continue reading at Moneyweek »

Investing